Stephanie Kaypee
Affiliations: | Tohoku University Graduate School of Medicine |
Google:
"Stephanie Kaypee"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Tapas Kundu | grad student | 2011-2017 | Jawaharlal Nehru Centre for Advanced Scientific Research |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sikder S, Kaypee S, Kundu TK. (2020) Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: Implications in disease. Journal of Biosciences. 45 |
| Ghosh R, Kaypee S, Shasmal M, et al. (2019) Tumor suppressor p53-mediated structural reorganization of the transcriptional coactivator p300. Biochemistry |
| Deota S, Rathnachalam S, Namrata K, et al. (2019) Allosteric Regulation of Cyclin-B Binding by the Charge State of Catalytic Lysine in CDK1 Is Essential for Cell Cycle Progression. Journal of Molecular Biology |
| Kaypee S, Sahadevan SA, Patil S, et al. (2018) Mutant and Wild-Type Tumor Suppressor p53 Induces p300 Autoacetylation. Iscience. 4: 260-272 |
| Senapati P, Dey S, Sudarshan D, et al. (2018) Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation. The Febs Journal |
| Kaypee S, Sahadevan SA, Sudarshan D, et al. (2018) Oligomers of human histone chaperone NPM1 alter p300/KAT3B folding to induce autoacetylation. Biochimica Et Biophysica Acta |
| Babu A, Kamaraj M, Basu M, et al. (2018) Chemical and genetic rescue of an ep300 knockdown model for Rubinstein Taybi syndrome in zebrafish. Biochimica Et Biophysica Acta |
| Kaypee S, Sudarshan D, Shanmugam MK, et al. (2016) Aberrant Lysine Acetylation in Tumorigenesis: Implications in the Development of Therapeutics. Pharmacology & Therapeutics |
| Naiya G, Kaypee S, Kundu TK, et al. (2015) A Constrained Helical Peptide Against S100A4 Inhibits Cell Motility in Tumor Cells. Chemical Biology & Drug Design |
| Wu M, Kim SH, Datta I, et al. (2015) Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice. Oncotarget. 6: 6136-50 |